Caspase-2 activation in the absence of PIDDosome formation by Manzl, Claudia et al.
JCB: ARTICLE
The Rockefeller University Press    $30.00
J. Cell Biol. Vol. 185 No. 2  291–303
www.jcb.org/cgi/doi/10.1083/jcb.200811105 JCB 291
Correspondence to Andreas Villunger: Andreas.Villunger@i-med.ac.at
Abbreviations used in this paper: DD, death domain; GAPDH, glyceraldehyde-
3-phosphate dehydrogenase; MEF, mouse embryonic fibroblast; MOMP, mito-
chondrial  outer  membrane  permeabilization;  mPIDD,  mouse  PIDD;  NF-B, 
nuclear factor B; PE, phycoerythrin; PI, propidium iodide; Puma, p53 up-
regulated modulator of apoptosis; UVR, UV radiation.
Introduction
PIDD (p53-induced protein with a death domain [DD]) was 
identified as one of many transcriptional targets that may medi-
ate apoptosis induction by the tumor suppressor p53 (Lin et al., 
2000). PIDD is widely expressed in various organs and cell 
types and is characterized by the presence of certain struc-
tural motives, including Leu-rich repeats, ZU5 domains, and a 
C-terminal DD (Tinel and Tschopp, 2004). DD-containing pro-
teins play important roles in the formation of multimeric signal-
ing complexes that regulate diverse cellular responses, including 
cytokine secretion, nuclear factor B (NF-B) activation, cell 
survival, and apoptosis (Reed et al., 2004). RAIDD (receptor-
interacting protein-associated ICH-1/CED-3 homologous pro-
tein with a DD), a bipartite adapter molecule, was identified as 
a  possible  interaction  partner  of  PIDD  (Tinel  and Tschopp, 
2004). RAIDD contains a caspase recruitment domain as well 
as a C-terminal DD (Duan and Dixit, 1997). The caspase re-
cruitment domain of RAIDD was previously described to inter-
act with pro–caspase-2 (Duan and Dixit, 1997) and has been 
implicated in the activation of this ill-defined initiator caspase 
thought to be required for DNA damage–induced apoptosis in 
certain tumor cells and the metabolic death of oocytes (Degterev 
and Yuan,  2008). A  trimolecular  complex  containing  PIDD, 
RAIDD, and caspase-2 was subsequently identified as the   
long-sought-after activation platform of caspase-2 and dubbed 
the PIDDosome (Tinel and Tschopp, 2004). This complex appears 
to form spontaneously in cell extracts from different cell lines 
upon temperature shift in vitro, but formation in extracts from 
cells undergoing apoptosis after DNA damage has not been de-
tected so far (Read et al., 2002). A second, PIDD-containing 
multimeric protein complex was described shortly thereafter 
that  contains  the  Ser-Thr  kinase  RIP-1  (receptor-interacting 
protein 1) and IKK-/NF-B essential modulator, the regula-
tory subunit of the IB kinase complex, which were both impli-
cated in the activation of NF-B signaling after genotoxic stress 
(Janssens et al., 2005). Subsequent analysis revealed that PIDD 
possesses autoproteolytic activity, facilitating the generation of 
two  different  active  protein  fragments,  termed  PIDD-C  and 
PIDD-CC. Although PIDD-CC was proposed to be required for 
  P
IDD  (p53-induced  protein  with  a  death  domain 
[DD]), together with the bipartite adapter protein 
RAIDD (receptor-interacting protein-associated ICH-1/ 
CED-3 homologous protein with a DD), is implicated in 
the activation of pro–caspase-2 in a high molecular weight 
complex called the PIDDosome during apoptosis induc-
tion after DNA damage. To investigate the role of PIDD in 
cell death initiation, we generated PIDD-deficient mice. 
Processing of caspase-2 is readily detected in the ab-
sence of PIDDosome formation in primary lymphocytes.   
Although caspase-2 processing is delayed in simian virus 
40–immortalized pidd
/ mouse embryonic fibroblasts, it 
still depends on loss of mitochondrial integrity and effec-
tor caspase activation. Consistently, apoptosis occurs nor-
mally  in  all  cell  types  analyzed,  suggesting  alternative 
biological  roles  for  caspase-2  after  DNA  damage.   
Because loss of either PIDD or its adapter molecule RAIDD 
did not affect subcellular localization, nuclear translocation, 
or caspase-2 activation in high molecular weight complexes, 
we suggest that at least one alternative PIDDosome- 
independent mechanism of caspase-2 activation exists in 
mammals in response to DNA damage.
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ple modes of regulation of PIDD protein expression (Cuenin 
et al., 2008). Although all of these findings support a critical 
role for PIDD in cell death and caspase-2 activation, targeting 
RAIDD or PIDD expression by siRNA failed to interfere with 
caspase-2 processing in response to 5-fluoruracil treatment in 
HCT-116 colon carcinoma cells (Vakifahmetoglu et al., 2006). 
In addition, thymocytes and fibroblasts from mice lacking 
RAIDD were reported to respond normally to cell death induc-
tion by DNA-damaging agents or TNF (Berube et al., 2005). 
However, cell death induced by overexpression of PIDD in 
fibroblasts strictly depended on the presence of RAIDD but not 
caspase-2, suggesting that PIDD can also engage cell death in 
a manner independent of this initiator caspase (Berube et al., 
2005). To investigate the relevance of PIDD for caspase-2 acti-
vation and cell death under physiological conditions, we have 
generated a PIDD-deficient mouse model by homologous re-
combination in embryonic stem cells.
activation of caspase-2 and cell death, PIDD-C was suggested 
to activate NF-B, DNA repair, and survival after low grade 
DNA damage (Tinel et al., 2007).
Consistent with a proapoptotic role for PIDD in p53-
induced cell death, its overexpression facilitated caspase-2 acti-
vation and cell death induction in response to DNA damage in 
HeLa cells (Tinel and Tschopp, 2004), and RNA interference or 
antisense oligonucleotides targeting PIDD mRNA delayed cell 
death induced by overexpression of p53 in H1299 colon cancer 
(Baptiste-Okoh et al., 2008) or K562 myelogenous leukemia 
cells, respectively (Lin et al., 2000). Interestingly, a correlation 
between apoptotic index and PIDD expression was recently re-
ported in oral squamous cell carcinoma patient samples, whereas 
no correlation was found regarding the p53 mutation status in 
these tumors (Bradley et al., 2007). The latter finding is consis-
tent with the observation that the basal expression of PIDD does 
not depend on the presence of functional p53, suggesting multi-
Figure 1.  Targeting the pidd locus in mice. (A) Schematic representation of the pidd/lrdd gene locus on mouse chromosome 7 (chr 7). Exons 3–15 of the 
pidd gene were replaced by the open reading frame of -galactosidase. The loxP element-flanked neomycin selection marker cassette was removed in vivo by 
cre-mediated deletion. The locations of the 5 and 3 probes used for Southern blot analysis are indicated as horizontal black bars. (B) Southern blot analysis 
on genomic DNA derived from wild-type, pidd
+/, and pidd
/ mice. (C) Exon-specific PCR using three different primer pairs spanning exons 7–8 or 13–15 
confirmed correct targeting of the pidd gene. (D) RT-PCR was performed on cDNA generated from total RNA derived from thymocytes (top two panels) that 
were left untreated or exposed to 2.5 Gy of  irradiation or SV40-immortalized wild-type (wt) and PIDD-deficient MEFs (bottom two panels) cultured in the 
absence or presence of etoposide to confirm absence of pidd mRNA. (E) Western blot analysis on thymocyte extracts derived from wild-type and pidd
/ mice 
before and after exposure to  irradiation in vitro confirmed absence of PIDD at the protein level. The asterisk indicates nonspecific (n.s.) bands.293 PIDDOSOME-INDEPENDENT CASPASE-2 ACTIVATION • Manzl et al.
assessment failed to reveal any gross abnormalities, and pidd
/ 
mice show normal lymphocyte development and subset distri-
bution in the relevant primary and secondary lymphatic organs 
(Fig. S2 A and not depicted). Collectively this demonstrates that 
PIDD is dispensable for embryonic development and postnatal 
life in unstressed animals.
Loss of PIDD fails to protect lymphocytes 
from apoptosis induction
To investigate the role of PIDD in cell death induction, we iso-
lated primary thymocytes as well as mature T and B cells from 
spleen and granulocytes from bone marrow by FACS sorting 
from age-matched wild-type, pidd
/, and caspase-2
/ mice. 
Lymphocytes overexpressing antiapoptotic Bcl-2 in all hemato-
poietic cells and cells lacking p53 or its proapoptotic target gene 
puma
/, a BH3-only Bcl-2 family member (Villunger et al., 
2003), were included in some of our assays as internal controls. 
Thymocytes  were  put  in  culture  without  further  treatment 
(spontaneous death) or exposed to DNA damage triggered by 
topoisomerase  II  inhibitor  etoposide,  the  DNA-intercalating 
drug doxorubicin, or  or UV irradiation. In parallel, cells were 
also exposed to heat stress or were treated with the broad-spectrum 
kinase inhibitor staurosporine, the ER stressors tunicamycin, 
brefeldin A, or thapsigargin as well as cytochalasin D or taxol, 
both of which disrupted cytoskeletal structures, or to death   
receptor agonists Fas ligand or TNF- (Table I). Cell viabil-
ity was monitored over time using Annexin V/propidium iodide 
(PI) staining and flow cytometric analysis. Loss of PIDD failed 
to protect thymocytes (Fig. 2), mature T and B cells, or granu-
locytes (not depicted) from any of the tested cell death stimuli. 
In contrast, overexpression of Bcl-2 or loss of p53 or puma 
each efficiently protected thymocytes and mature T and B   
cells from DNA damage–induced apoptosis (Fig. 2 and not de-
picted), which is consistent with previous results (Villunger et al., 
2003; Erlacher et al., 2006). To test whether the proposed 
Results
Generation of PIDD-deficient mice
Our targeting strategy aimed to replace exons 3–15 of the PIDD 
locus, replacing all relevant protein domains with the open read-
ing frame of -galactosidase followed by a loxP element-flanked 
neomycin resistance cassette (Fig. 1 A). Correct targeting of the 
pidd locus was confirmed by Southern blot analysis and exon-
specific PCR on genomic DNA derived from embryonic stem 
cells and, subsequently, tail tissue, mouse embryonic fibroblasts 
(MEFs), and liver derived from wild-type, pidd
+/, and pidd
/ 
mice (Fig. 1, B and C; and not depicted). RT-PCR analysis was 
performed to confirm the absence of pidd mRNA in thymocytes 
and SV40-immortalized MEFs (Fig. 1 D). Finally, to ascertain 
lack of protein, a polyclonal antiserum was generated using the 
DD of PIDD (aa 770–910) as immunogen. Reactivity of the 
affinity-purified IgG fraction was confirmed in MEFs that over-
express a Flag-tagged version of mouse PIDD (mPIDD). Three 
protein fragments corresponding to the full-length protein, pro-
cessed PIDD-C, and PIDD-CC were detected by the anti-Flag 
antibody and the purified anti-PIDD IgG fraction (Fig. S1 and 
not depicted). Transient cotransfection of 293T cells with an 
expression construct encoding mPIDD together with two differ-
ent lentiviral vectors encoding alternative short hairpin RNAs 
targeting mPIDD confirmed specificity of the purified anti-
serum (Fig. S1 and not depicted). Western blot analysis performed 
on thymocyte extracts derived from wild-type and pidd
/ mice 
revealed that PIDD-CC appears to be the only detectable form 
(Fig. 1 E). Efforts to identify endogenous full-length protein or 
PIDD-C by immunoblotting or immunoprecipitation were re-
peatedly unsuccessful, suggesting that PIDD may be rapidly 
autoprocessed in thymocytes (unpublished data).
Mice lacking both alleles of PIDD were born in normal 
Mendelian frequency and did not show fertility problems, gen-
der bias, or any other overt phenotype. Furthermore, histological 
Table I.  Summary of stimuli and final concentrations used to induce cell death
Stimulus Primary  
thymocytes
Splenic  
B cells
Splenic  
T cells
Bone marrow  
granulocytes
SV40-immortalized  
MEFs
Primary  
MEFs
Etoposide 1 µg/ml 1 µg/ml 1 µg/ml 1–10 µg/ml 10 – 50 µg/ml 10–50 µg/ml
Doxorubicin 400 ng/ml 400 ng/ml 400 ng/ml 400 ng/ml ND ND
Cisplatin 25–100 µM 50 µM 50 µM 50 µM 20 µM ND
Staurosporine 100 and 500 nM 100 nM 100 nM 100 and 500 nM 50 nM ND
Ionomycin 1 µg/ml ND ND ND ND ND
PMA 10 ng/ml ND ND ND ND ND
Velcade 50 ng/ml 50 ng/ml 50 ng/ml ND ND ND
Trichostatin A 50 nM 50 nM 50 nM ND ND ND
Dexamethasone 10
7 M 10
7 M 10
7 M ND ND ND
TNF- 10 ng/ml 10 ng/ml 10 ng/ml 10 ng/ml 30 ng/ml ND
Cycloheximide 5 µg/ml 5 µg/ml 5 µg/ml 5 µg/ml 5 µg/ml ND
Super Fas ligand 10 ng/ml 10 ng/ml 10 ng/ml 10 ng/ml ND ND
Cytochalasin D 2 µM ND ND ND 20 µM 20 µM
Taxol 500 µM ND ND ND 100 µM 100 µM
Vincristine ND ND ND ND ND 50 µg/ml
Tunicamycin 0.1–5 µg/ml 1 µg/ml 1 µg/ml ND 1.2 µg/ml ND
Brefeldin A 1.25 and 2.5 µg/ml ND ND ND 1 µg/ml ND
Thapsigargin 0.05–0.1 µg/ml ND ND ND 50 µg/ml 50 µg/mlJCB • VOLUME 185 • NUMBER 2 • 2009   294
Higher doses of UVR, etoposide treatment, or transient expo-
sure to 45°C did not allow clonal survival of primary (Fig. S3) 
or immortalized cells (Fig. S4) independent of their genotypes.
To address the possible relevance of PIDD for transient, 
short-term  survival,  primary  as  well  as  SV40-immortalized 
MEFs were analyzed for their initial cell death responses. MEFs 
from wild-type, pidd
/, caspase-2
/, or puma
/ mice (Fig. 3 A) 
as well as primary low passage wild-type and pidd
/ or cas-
pase-2
/ MEFs (Fig. 3 B) were exposed to DNA damage in-
duced by etoposide, UV irradiation, serum deprivation, heat 
stress, ER stress, cytochalasin D, taxol, or staurosporine (Table I), 
but, again, neither loss of PIDD nor of caspase-2 protected these 
cells significantly from any of these apoptotic stimuli. In con-
trast, loss of puma transiently protected MEFs from the effects 
of DNA damage (Fig. 3 A and not depicted).
To gain insight into possible minor mechanistic differ-
ences in apoptosis induction too subtle to be captured by An-
nexin V/PI staining, we also investigated the impact of PIDD 
deficiency  on  mitochondrial  membrane  depolarization  using 
JC-1 staining (Fig. 4 A) and by monitoring cytochrome c release 
(Fig. 4 B). In SV40-immortalized fibroblasts (Fig. 4) or thymo-
cytes (not depicted) exposed to DNA damage, none of these 
parameters was significantly altered as a result of the absence   
of PIDD or caspase-2, but, again, loss of p53 or Puma par-
tially blocked these events upon DNA damage. To backup our 
PIDD–RAIDD–caspase-2 apoptosis pathway could act in a re-
dundant manner with the Bcl-2–regulated one, we also assessed 
survival  in  thymocytes  lacking  PIDD  and  p53  up-regulated 
modulator of apoptosis (Puma) simultaneously. However, the 
degree of protection from apoptosis induced upon DNA dam-
age  was  comparable  between  puma
/  and  pidd
/puma
/ 
double-deficient thymocytes (Fig. 2), arguing against such re-
dundancy. To exclude the possibility that loss of PIDD may 
have an impact on the survival of lymphocytes in vivo, masked 
by the lack of coregulatory factors in our in vitro analysis, we 
also exposed wild-type and pidd
/ mice to graded doses of 
whole body irradiation (2.5 and 5.0 Gy) and evaluated lympho-
cyte cellularity as well as subset distribution of immature and 
mature T and B cells in thymus, bone marrow, and spleen 20 h 
after irradiation. Consistent with our findings in vitro, loss of 
PIDD did not enhance the survival of lymphocytes after irradia-
tion in vivo (Fig. S2 A and not depicted).
Because PIDD has been implicated in caspase-2–mediated 
apoptosis as well as NF-B activation, enabling DNA repair 
(Janssens et al., 2005), we investigated the impact of loss of 
PIDD on clonal survival after DNA damage in primary as well 
as SV40-immortalized MEFs transiently exposed to heat shock, 
etoposide, UV radiation (UVR) or  irradiation. Loss of PIDD 
or caspase-2 did not influence residual survival of MEFs ob-
served upon low dose of UVR or transient exposure to 43°C. 
Figure 2.  PIDD is dispensable for cell death induction in lymphocytes. Thymocytes derived from mice of the indicated genotypes were put in culture with-
out further treatment (spontaneous cell death) or exposed to apoptosis inducers as indicated over time. Cell death was monitored by Annexin V–FITC/PI 
staining and flow cytometric analysis at the indicated time points. Data are means ± SD from four to eight independent experiments per genotype, with the 
exception of pidd
/puma
/ (n = 2). The extent of apoptosis induced specifically by different stimuli was calculated by the equation (induced apoptosis  
spontaneous cell death)/(100  spontaneous cell death). No significant differences in cell death induction were observed between wild-type and PIDD- and 
caspase-2–deficient cells treated with any of the indicated stimuli by analysis of variance.295 PIDDOSOME-INDEPENDENT CASPASE-2 ACTIVATION • Manzl et al.
of cells to etoposide treatment or  irradiation. However, pro-
cessing occurred with similar efficiency in wild-type and PIDD-
deficient cells and coincided with the appearance of the active 
form of caspase-3, indicating that the classical mitochondrial 
outer  membrane  permeabilization  (MOMP)–apoptosome-
mediated apoptosis pathway was active either preceding caspase-2 
cleavage or caspase-2 may have been activated in a dimerization-
dependent manner in a parallel pathway (Fig. 5 A). However, 
because processing of both caspases was efficiently blocked in 
thymocytes overexpressing Bcl-2 (Fig. 5, B and C), we con-
clude  that  caspase-2  processing  requires  MOMP  and  cyto-
chrome c release, at least under the conditions tested in this 
study. Thymocytes lacking Puma showed a significant delay 
but, in contrast to Bcl-2–overexpressing cells, not a complete 
block in caspase-2 processing (Fig. 5, B and C), indicating that 
additional effector proteins such as Noxa or Bim contribute to 
DNA damage–induced thymocyte apoptosis, as shown previ-
ously (Erlacher et al., 2006; Michalak et al., 2008). Importantly, 
caspase-2 processing occurred with similar decreased efficiency 
in thymocytes lacking Puma or PIDD and Puma simultaneously, 
demonstrating that caspase-2 cleavage during DNA damage–
induced thymocyte apoptosis triggered by  irradiation (Fig. 5 D) 
or etoposide treatment (not depicted) requires MOMP and that 
PIDD does not contribute to caspase-2 processing under these 
conditions, not even in a redundant manner with the Bcl-2–
regulated activation pathway.
Somewhat surprisingly, in contrast to our observations 
in primary lymphocytes, caspase-2 processing was delayed in 
SV40-immortalized MEFs lacking PIDD. This coincided with 
slightly reduced levels of activated caspase-3 (Fig. 6 A) and 
could be interpreted in a manner that caspase-2 may be able   
to act upstream of MOMP or in a parallel PIDD-dependent 
observations, excluding a role for the PIDDosome in cell death 
induction,  we  also  included  raidd
/  MEFs  in  our  analysis. 
Consistent with our results using PIDD-deficient MEFs, raidd
/ 
MEFs also responded like wild-type cells to cell death induction 
by etoposide or staurosporine treatment (Fig. 4, A and B).
Caspase-2 processing is normal in primary 
lymphocytes but delayed in immortalized 
MEFs lacking PIDD
To investigate the potential role of PIDD and RAIDD in caspase-2 
processing, which can occur independent of dimerization-
induced activation, we first analyzed caspase-2 cleavage (pro-
cessing) in protein lysates extracted from primary thymocytes 
and SV40-immortalized MEFs derived from wild-type, PIDD-
deficient, and RAIDD-deficient mice upon DNA damage. 
Again, cells overexpressing Bcl-2 and deficient for p53 or puma 
were included in our analysis as controls. By using a monoclo-
nal antibody (clone 11B4) that recognizes the large subunit of 
caspase-2, we were able to detect its pro-form (50 kD) as well 
as an 32-kD fragment that arises from intrasubunit cleavage 
between the p20 and the p10 subunit during autoprocessing, 
after prior removal of the caspase recruitment domain, or pro-
cessing and the large subunit only (p20), which is generated by 
subsequent  autoproteolysis  or  proteolysis  of  the  pro-domain 
(O’Reilly et al., 2002). Because the generation of these frag-
ments can also be caused by caspase-3–mediated cleavage of 
caspase-2, it has to be pointed out in this study that the appear-
ance of processed caspase-2 fragments in Western blotting 
analysis does not necessarily reflect its true dimerization-
induced activation.
In primary thymocytes (Fig. 5) and splenocytes (not de-
picted), cleaved caspase-2 was readily detectable after exposure 
Figure 3.  Normal cell death responses in pri-
mary and SV40-immortalized MEFs. (A and B)   
SV40-immortalized  MEFs  (A)  and  primary 
MEFs (B) from mice of the indicated genotypes 
were  put  in  culture  without  further  treatment 
(spontaneous cell death) or exposed as indi-
cated over time. Cell death was monitored by 
Annexin V–FITC/PI staining and flow cyto-
metric analysis at the indicated time points. Data 
are means ± SD from three independent exper-
iments performed in duplicate using SV40- 
immortalized MEFs and two to three indepen-
dent experiments performed in duplicate using 
primary MEFs. The extent of apoptosis induced 
specifically by different stimuli was calculated 
by the equation (induced apoptosis  spon-
taneous cell death)/(100  spontaneous cell 
death). wt, wild type.JCB • VOLUME 185 • NUMBER 2 • 2009   296
and wild-type MEFs or thymocytes (unpublished data). There-
fore, we limited our efforts to investigate the proteolytic activity 
of caspase-3/7 during cell death induction in extracts derived from 
wild-type, pidd
/, caspase-2
/, or p53
/ SV40-immortalized 
MEFs after treatment with etoposide, serum deprivation, or 
exposure to UV irradiation. Caspase-3/7 activity (Ac-DEVD-
AMC cleavage) was comparable in wild-type and caspase-2– and 
PIDD-deficient cell lysates, whereas lysates from p53-deficient 
cells showed reduced activity in response to etoposide treatment 
at the time of analysis (Fig. S5 A). A time course comparing 
caspase-3/7–like  activities  in  etoposide-treated  thymocytes 
expressing or lacking PIDD also failed to reveal significant dif-
ferences between genotypes (Fig. S5 B).
Collectively, our findings suggest that PIDD is not required 
to trigger caspase-2 processing in response to DNA damage 
in primary lymphocytes and that caspase-2 cleavage is effec-
tively prevented by the maintenance of mitochondrial integrity   
pathway in immortalized MEFs, as previously reported for 
certain  tumor  cell  lines  by  others  (Robertson  et  al.,  2002, 
2004). To investigate whether caspase-2 processing can occur 
independent of effector caspase activation in SV40-immortalized 
MEFs and, thus, MOMP, we investigated processing of caspase-2 
in response to DNA damage in MEFs lacking both caspase-3 
and -7. However, in these cells, caspase-2 cleavage did not occur 
in response to etoposide treatment or UV irradiation (Fig. 6 B). 
This demonstrates that processing of caspase-2, usually ob-
served during DNA damage–induced apoptosis, depends on the 
presence of caspase-3 and/or -7 and is a secondary event down-
stream of effector caspase activation.
As previously pointed out by others, fluorescence-based 
caspase-substrate cleavage assays cannot be used to quantify 
caspase-2 activity (McStay et al., 2008), and, in fact, we ob-
served that the supposedly caspase-2–specific substrate Ac-VD-
VAD-AMC was equally well processed in caspase-2–deficient 
Figure 4.  Impact of PIDDosome loss on mitochondrial function and cytochrome c release. (A) Mitochondrial membrane potential was determined by JC-1 
staining, and representative FACS blots of control and etoposide-treated SV40-immortalized MEFs are depicted. The bar graph shows quantification of 
FACS analysis using JC-1 staining of SV40-immortalized MEFs of the indicated genotypes 24 h after treatment. (B) Cytochrome c release was monitored in 
untreated or etoposide- or staurosporine-treated SV40-immortalized MEFs after 24 h by flow cytometric analysis. Representative FACS blots of control and 
etoposide-treated SV40-immortalized MEFs are depicted. The bars represent the percentage of cells that released cytochrome c. (A and B) The bar graphs 
represent the means ± SEM of n ≥ 3 independent experiments per genotype and treatment. *, P < 0.05 compared with wild type (wt).297 PIDDOSOME-INDEPENDENT CASPASE-2 ACTIVATION • Manzl et al.
spontaneously  upon  cell  rupture  followed  by  a  temperature 
shift in HeLa or 293T cell extracts (Tinel and Tschopp, 2004). 
To investigate whether caspase-2 can still be recruited into this 
high molecular weight fraction in the absence of components 
of the PIDDosome, we performed gel filtration analysis on 
extracts derived from wild-type, pidd
/, or raidd
/ SV40- 
immortalized MEFs before and after temperature shift. Immuno-
blotting of eluted fractions after size-exclusion chromatography 
revealed that a high molecular weight complex of ≥670 kD 
containing caspase-2 is formed in all genotypes analyzed upon 
incubation of cell extracts at 37°C (Fig. 7 A). To monitor for 
quantitative differences in recruitment, we also directly com-
pared caspase-2 levels in the high molecular weight fractions 
of all genotypes investigated, but comparable amounts were 
detected in wild-type, RAIDD- and PIDD-deficient extracts 
(Fig. 7 B). Together, this suggests that the formation of this 
complex containing multimerized caspase-2 can occur inde-
pendently of PIDD or RAIDD.
Finally, we also investigated subcellular localization of 
caspase-2 in MEFs lacking PIDD or RAIDD before and after 
DNA damage by immunostaining and laser-scanning micros-
copy. Endogenous caspase-2 was found mainly in the cytoplasm 
in untreated MEFs, but a significant portion appeared to translocate 
into the nucleus after etoposide treatment, which is consistent 
by Bcl-2 family proteins. However, in SV40-immortalized MEFs 
lacking PIDD, caspase-2 processing is less effective, perhaps 
as the result of impaired p53 function, albeit still depends on 
effector caspase activation upon DNA damage. Regardless, 
reduced caspase-2 activation in the absence of PIDD does not 
translate into increased short-term (Figs. 2 and 3) or long-term 
clonal survival in response to the stimuli tested in this study 
(Figs. S3 and S4).
Caspase-2 multimerization and  
activation can occur in the absence  
of the PIDDosome
As mentioned in the previous section, monitoring cleavage of 
initiator caspases is not indicative for their activation in re-
sponse to external signals because this can also be mediated by 
activated effector caspases (Riedl and Salvesen, 2007). Dimer-
ization and subsequent autoprocessing in high molecular weight 
complexes such as the Apaf-1 containing apoptosome, the death-
inducing signaling complex, or the PIDDosome are considered the 
initial activating events for pro–caspase-9 or -8 or pro–caspase-2 
(Riedl and Salvesen, 2007).
Recruitment  of  pro–caspase-2  into  a  high  molecular 
weight complex of ≥670 kD, together with the components of 
the PIDDosome, RAIDD and PIDD, has been reported to occur 
Figure 5.  Caspase-2 processing occurs in thymocytes lacking the PIDDosome. (A) Thymocytes isolated from wild-type (wt) and pidd
/ mice were cultured 
without further treatment or stimulated with etoposide. Caspase-2 processing and cleavage of effector caspase-3 was monitored over time by Western blot 
analysis. The asterisk indicates a residual caspase-2 signal remaining upon reprobing with anti-GAPDH antibody. (B and C) Caspase-2 and -3 processing 
in etoposide-treated (B) or -irradiated thymocytes (C) of the indicated genotypes. tg, transgenic. (D) Thymocytes isolated from wild-type, pidd
/, puma
/, 
and pidd
/puma
/ mice were cultured without further treatment or after exposure to  irradiation for 6 h. Caspase-2 processing and cleavage of effector 
caspase-3 were monitored by Western blot analysis. After detection of caspase-2, membranes were first stripped and reprobed with anti–active caspase-3 
antibody and finally probed without stripping with an antibody recognizing GAPDH or -tubulin to compare protein loading. DKO, double knockout.JCB • VOLUME 185 • NUMBER 2 • 2009   298
transformed human cancer cell lines (Tinel and Tschopp, 2004; 
Baptiste-Okoh et al., 2008). Our study clearly indicates that PIDD 
and caspase-2 are dispensable for apoptosis induction in re-
sponse to DNA damage, growth factor deprivation, ER stress, 
disruption of cytoskeletal architecture, and pan-kinase inhibition 
as well as Fas ligand– or TNF-–induced cell death in lympho-
cytes and SV40-transformed MEFs (Figs. 2 and 3). Loss of mito-
chondrial membrane potential or release of cytochrome c was 
also not delayed in cells lacking caspase-2, RAIDD, or PIDD 
(Fig. 4). Collectively, this demonstrates that the PIDDosome is 
not required for efficient apoptosis induction in response to a wide 
range of stimuli, including DNA damage (Table I). It is unclear 
at present whether apoptosis induced by overexpression of p53 
is impaired in PIDD-deficient cells, as suggested by knockdown 
experiments  in  H1299  carcinoma  cells  (Baptiste-Okoh  et  al., 
2008), but stabilization of p53 by adding the Mdm2 inhibitor 
Nutlin-3a killed PIDD-deficient MEFs as effectively as wild-type 
cells while sparing p53
/ MEFs, arguing against a prominent 
role for PIDD in p53-induced apoptosis (unpublished data).
Caspase-2 processing occurred with comparable kinetics 
in wild-type, raidd
/, and pidd
/ thymocytes after DNA dam-
age and was always observed concomitantly with the appearance 
of the activated form of caspase-3 (Fig. 5). Similar observations 
have been made in HCT116 cells treated with PIDD- or RAIDD-
specific siRNA, but the cleavage of caspase-2 observed in re-
sponse to 5-fluoruracil treatment in these cells was attributed 
to incomplete knockdown of the PIDDosome components 
(Vakifahmetoglu et al., 2006). However, our observations re-
ported in this study suggest that caspase-2 cleavage occurs sec-
ondary to MOMP and activation of the classical apoptosome during 
apoptosis induced by DNA damage. Consistently, all of these 
events were blocked by preserving mitochondrial integrity,   
either by overexpression of Bcl-2 or loss of Puma (Fig. 5). Impor-
tantly, PIDD also does not act in a redundant manner with the 
Bcl-2–regulated pathway of caspase-2 processing, as its cleav-
age, as well as cell death, is comparable in puma
/ and pidd
/ 
puma
/ cells (Figs. 2 and 5). Our data on caspase-2 processing 
are in line with the observation that its cleavage depends on 
the presence of Apaf-1 and caspase-9 in primary lymphocytes 
(O’Reilly et al., 2002; Marsden et al., 2004) and cannot be used 
as a readout for its activation during apoptosis induction and 
contradict reports where activation of caspase-2 was positioned 
upstream of MOMP and cytochrome c release in response to 
DNA damage in tumor cell lines such as Jurkat or HeLa cells or 
when recombinant caspase-2 was added directly to isolated mito-
chondria (Guo et al., 2002; Robertson et al., 2002, 2004). Pri-
mary MEFs lacking caspase-2 were also reported to resist cell 
death induced by disruption of the cytoskeleton (Ho et al., 2008), 
which we failed to observe in SV40-immortalized MEFs (Fig. 3 A). 
All of these differences may be inherent to the cell types ana-
lyzed and/or the mode of immortalization/transformation, which 
can affect the apoptotic response of cells in a highly diverse 
manner. In line with the latter, we also observed that caspase-2 
processing was delayed in pidd
/ SV40-immortalized MEFs 
(Fig. 6 A). This phenomenon was observed in independent clones 
derived  from  individual  mouse  embryos  (unpublished  data). 
Nevertheless, MEFs of both genotypes were equally sensitive to 
with previous results (Colussi et al., 1998). However, loss of 
raidd or pidd did not influence the subcellular distribution or 
translocation of caspase-2 in response to DNA damage, as as-
sessed by immunofluorescence analysis (Fig. 8). In addition, we 
monitored cytoplasmic to nuclear translocation of caspase-2 in 
wild-type and PIDD-deficient MEFs after exposure to  irradia-
tion by Western blot analysis but again failed to observe signifi-
cant differences between genotypes regarding caspase-2 nuclear 
translocation (Fig. 9). In summary, these results indicate that an 
additional platform for caspase-2 activation exists in mamma-
lian cells or that caspase-2 can multimerize and autoprocess in 
the absence of such a platform.
Discussion
We have generated mice that lack the p53-induced protein PIDD 
and found that its absence does not interfere with normal mouse 
development, caspase-2 activation, or cell death induction by 
several different apoptotic stimuli. Formation of the PIDDosome 
has previously been suggested to be rate limiting for activa-
tion  of  caspase-2  and  p53-induced  cell  death  in  several   
Figure 6.  Caspase-2 processing is delayed in PIDD-deficient MEFs but 
still requires effector caspase activation. (A) Immortalized wild-type (wt) 
and pidd
/ SV40-MEFs were exposed to 50 µg/ml etoposide (Eto) or   
5 mJ/cm
2 UVR, and lysates were immunoblotted for caspase-2 processing, 
stripped, and reprobed with anti–active caspase-3 antibody followed by a 
reprobing with anti-GAPDH. (B) Wild-type and caspase-3/7 double-deficient 
SV40-MEFs were exposed to DNA damage as in A, and lysates were 
immunoblotted  for  caspase-2  processing.  After  detection  of  caspase-2, 
membranes were first stripped and reprobed with anti–active caspase-3 
antibody followed by an antibody recognizing GAPDH to compare protein 
loading. Finally, membranes were stripped before detection of caspase-7.299 PIDDOSOME-INDEPENDENT CASPASE-2 ACTIVATION • Manzl et al.
can also form in the absence of the PIDDosome upon tempera-
ture shift (Fig. 7, A and B) but contain the active form of the 
protease (Read et al., 2002). It will be important to demonstrate 
that such a high molecular weight complex containing caspase-2 
actually forms in whole cells in vivo upon apoptosis induction 
or may only be triggered in vitro upon temperature shift. 
Finally, subcellular localization of caspase-2 before and after 
exposure of cells to DNA damage was not affected by loss of 
PIDD or RAIDD, but, interestingly, caspase-2 accumulated in 
the nucleus of SV40-MEFs upon etoposide treatment before de-
tectable signs of apoptosis and the activation of effector cas-
pases (Figs. 8 and 9).
Collectively, our findings suggest that at least one alterna-
tive PIDDosome-independent mechanism of caspase-2 activa-
tion exists in mammals. Furthermore, caspase-2 dimerization 
and activation may even occur in the absence of any activating 
platform, as observed upon overexpression in bacteria. A local 
and transient increase in protein concentration either alone or in 
combination with one of the many described posttranslational 
modifications (Krumschnabel et al., 2009) may suffice to pro-
mote its full activation. Finally, we postulate that caspase-2 ac-
tivation by PIDD does not contribute to apoptosis induction but 
regulates events triggered in response to DNA damage such as 
cell cycle arrest or repair.
apoptosis in response to all stimuli tested (Fig. 3, A and B). 
Similar observations have been previously reported using MEFs 
lacking RAIDD (Berube et al., 2005). Nevertheless, cleavage of 
caspase-2 upon DNA damage strictly depended on the presence 
of activated effector caspase-3 and/or -7 (Fig. 6 B). All together, 
this suggests that the PIDDosome may contribute to caspase-2 
processing after DNA damage in an effector caspase-dependent 
manner. Although counterintuitive at first sight, effector cas-
pases appear to possess the potential to influence events consid-
ered to occur upstream of mitochondria such as the activation 
and translocation of Bax (Lakhani et al., 2006). Therefore, we 
propose that modulation of caspase-2 activity via the PIDDosome 
does not contribute to apoptosis but may rather influence other 
events triggered by DNA damage such as NF-B activation, cell 
cycle arrest, and/or DNA repair. Consistently, a role for PIDD 
and caspase-2 in G2/M checkpoint control and nonhomologous 
end joining of double-strand breaks was reported recently (Shi 
et al., 2009). However, our experiments investigating the role of 
PIDD in NF-B activation upon DNA damage are currently too 
preliminary to draw firm conclusions.
Finally, we also excluded that multimerization-induced 
activation of caspase-2 in high molecular weight complexes de-
pends on the presence of the PIDDosome because gel filtration 
analysis  revealed  that  such  caspase-2–containing  complexes 
Figure 7.  The PIDDosome is not required for the formation of high molecular weight complexes containing caspase-2. (A) Lysates from wild-type (wt), 
raidd
/, and pidd
/ SV40-immortalized MEFs were incubated at 4°C or 37°C for 1 h and subjected to size-exclusion chromatography, and fractions 
were precipitated, separated by SDS-PAGE, and immunoblotted with an anti–caspase-2 antibody (Ab). (B) Fractions 3–5, containing complexes ≥600 kD, 
and fractions 17–19, containing proteins of a molecular weight range of 75–40 kD, of all indicated genotypes were analyzed for the relative caspase-2 
expression level. Ponceau staining of the membranes was used to compare protein loading (bottom).JCB • VOLUME 185 • NUMBER 2 • 2009   300
T.W. Mak (University of Toronto, Toronto, Canada) and obtained on a 
mixed genetic background (72% C57BL/6 background). Caspase-3/7 
double-deficient MEFs were provided by R. Flavell (Yale School of Medi-
cine, New Haven, CT).
Materials and methods
Generation of pidd
/ mice and other mouse strains used
All animal experiments were performed in accordance with the Austrian 
Tierversuchsgesetz  (in  accordance  with  Austrian  legislation  BGB1  Nr. 
501/1988 i.d.F. 162/2005) and have been granted by the Bundesminis-
terium für Bildung, Wissenschaft und Kultur. To generate a pidd-targeting 
construct, C57BL/6 genomic DNA was isolated and subcloned from the 
Bac clone RPCI-23:141F19 (Roswell Park Cancer Institute), harboring the 
entire pidd locus (Fig. 1). Exons 3–15 in pidd were replaced with the open 
reading frame encoding -galactosidase followed by a loxP element-
flanked  neomycin  cassette.  Two  correctly  targeted  embryonic  stem  cell 
clones were identified by Southern blot analysis and subsequently injected 
into C57BL/6 blastocysts and delivered by CD1 surrogate mothers to gen-
erate chimeric mice. Chimaeras derived from both independent embryonic 
stem cell clones were mated with wild-type C57BL/6 mice. Germline trans-
mission was only obtained from one of these clones, and heterozygous   
offspring were used for the generation of pidd
/ mice. The neomycin 
resistance  marker  was  subsequently  removed  by  crossing  to  female 
C57BL/6 cre deleter mice (Schwenk et al., 1995).
With the exception of the in vivo irradiation experiments conducted 
with mice on mixed genetic background (B6/129SV; 1:1), all experi-
ments shown were performed on pidd
/ cells from mice that were back-
crossed onto C57BL/6 genetic background for eight generations. The 
generation of caspase-2
/ (provided by D.L. Vaux, LaTrobe University, 
Melbourne, Australia; O’Reilly et al., 2002), puma
/ (provided by A. 
Strasser, Walter and Eliza Hall Institute of Medical Research, Melbourne, 
Australia; Villunger et al., 2003), and vav-bcl-2 transgenic mice (pro-
vided by J. Adams, Walter and Eliza Hall Institute of Medical Research, 
Melbourne, Australia; Ogilvy et al., 1999), all maintained on C57BL/6 
genetic  background,  has  been  previously  described  (Villunger  et  al., 
2003). p53-deficient mice on C57BL/6 background were provided by 
M. Serrano (Centro Nacional de Investigaciones Oncológicas, Madrid, 
Spain). Mice deficient for raidd (Berube et al., 2005) were provided by 
Figure 8.  Subcellular localization of caspase-2 in the absence of PIDD or RAIDD. Localization of endogenous caspase-2 (green) was detected in wild-type 
SV40-immortalized MEFs and MEFs lacking pidd or raidd before (control) or after drug treatment (50 µg/ml etoposide). Cells were costained for p53 (red) 
and the nucleus detecting fluorochrome DAPI (blue). Overlays of all staining are depicted (merge).
Figure 9.  Nuclear translocation of caspase-2 upon DNA damage. Cyto-
solic and nuclear extracts from wild-type (wt) and PIDD-deficient MEFs were 
generated from untreated cultures or 4 h after exposure to 4 Gy of  
irradiation. Extracts were separated by SDS-PAGE, and caspase-2 was de-
tected by immunoblotting. Membranes were reprobed with antilamin- and 
antitubulin-specific antibodies to assess cross-contamination of fractions as 
well as anti–active caspase-3 to monitor for effector caspase activation. 
The asterisk indicates nonspecific (n.s.) bands.301 PIDDOSOME-INDEPENDENT CASPASE-2 ACTIVATION • Manzl et al.
cells were costained with FITC-conjugated Annexin V and 5 µg/ml PI and 
viability  was  assessed  by  flow  cytometric  analysis.  SV40-immortalized 
MEFs were cultured at a density of 40,000 cells in 12-well plates. To deter-
mine cellular viability, cells were stained with FITC-conjugated Annexin V 
and 5 µg/ml PI and analyzed by flow cytometry.
Quantification of mitochondrial membrane potential
SV40-immortalized MEFs were seeded into 6-well plates at 120,000 
cells per well and grown overnight before being stimulated with relevant 
cell death inducers for up to 24 h. Cells were harvested by trypsinization, 
washed once with excess PBS, resuspended in DME medium containing   
4 µM JC-1 (5,5,6,6-tetrachloro-1,1,3,3-tetraethylbenzimidazolcarbocya-
nine iodide; Sigma-Aldrich), and incubated for 20 min at 37°C in the dark. 
Cells were washed once again with PBS and resuspended in 200 µl PBS. 
Alterations in mitochondrial membrane potential were then estimated from 
changes in cell populations with high red and low green fluorescence (high 
mitochondrial potential) to cells with low red and high green fluorescence 
(low mitochondrial potential) as determined by FACS analysis.
Quantification of cytochrome c release
SV40-immortalized MEFs were grown to subconfluence on 6-cm dishes, 
stimulated as indicated, trypsinized, washed in PBS, and permeabilized by 
the addition of digitonin in 50 µg/ml PBS for 5 min at 4°C. After removing 
digitonin by centrifugation, cells were fixed with 4% PFA for 20 min at RT. 
Thereafter, cells were washed three times with PBS, and nonspecific bind-
ing was blocked using PBS containing 3% BSA and 0.05% saponin. Sub-
sequently, cells were incubated with anti–cytochrome c antibody (diluted to 
1:200 in blocking buffer; clone 7H8.2C12; BD) at 4°C overnight. Cells 
were washed three times in PBS, and Alexa Fluor 488–labeled anti–mouse 
(Invitrogen) was used as secondary antibody at a dilution of 1:100 in 
blocking solution and incubated for 1 h at RT. After three further washing 
steps, cells were resuspended in PBS, and cytochrome c release was deter-
mined by flow cytometric analysis.
Biochemical fractionation and immunoblot analysis
Cells were harvested and lysed for 1 h on ice in lysis buffer (1% CHAPS, 
20 mM Tris-HCl, pH 7.5, 5 mM MgCl2, 137 mM KCl, 1 mM EDTA, 1 mM 
EGTA, 0.5 mM PMSF, 5 mM NaF, and 2 mM Na3VO4; Roche), and the 
protein  concentration  was  determined  using  Bradford  reagent  (Bio-Rad 
Laboratories). Protein was separated by SDS-PAGE, transferred to a nitro-
cellulose membrane, and incubated with the relevant antibodies (caspase-2 
[11B4; Enzo Biochem, Inc.]; cleaved caspase-3 [Asp175; 5A1], caspase-3 
[8G10], and caspase-7 [cs-9492; all from Cell Signaling Technology]; 
glyceraldehyde-3-phosphate dehydrogenase [GAPDH; 71.1; Sigma-Aldrich]; 
and -tubulin [DM1A; Santa Cruz Biotechnology, Inc.]). Blots were visual-
ized by enhanced chemiluminescence (GE Healthcare).
Size chromatography and gel filtration
SV40-immortalized MEFs were washed in PBS and resuspended in a hypo-
tonic buffer containing 20 mM Hepes-KOH, 10 mM KCl, 1 mM MgCl2, 1 mM 
EDTA, 1 mM EGTA, pH 7.5, and Complete Protease Inhibitor Cocktail (Roche). 
Resuspended cells were subjected to three rounds of freeze thawing using 
liquid nitrogen. Cellular debris was removed by centrifugation at 10,000 g for 
20 min at 4°C followed by filtration through a 0.5-µm mesh. Cell extracts were 
incubated at 37°C or 4°C for 60 min and then subjected to size exclusion 
chromatography. Treated lysates were fractionated using a fast protein liquid 
chromatography protein purification system on a sorbent (Ultrogel AcA 34; 
Pall Life Sciences) in a column (Tricorn10/600; GE Healthcare) at 4°C. The 
column was equilibrated with hypotonic buffer, 1.5–2 mg protein lysates was 
applied and eluted from the column with the same buffer at a constant flow 
rate of 0.5 ml/min, and 1-ml fractions were collected. The column was cali-
brated with GE Healthcare gel filtration standards containing bovine thyro-
globulin (670 kD), aldolase (158 kD), conalbumin (75 kD), and ovalbumin   
(43 kD). Each fraction from the gel filtration was precipitated with TCA at a 
final concentration of 13% (vol/vol), and samples were incubated for 5 min 
at 20°C followed by 15 min at 4°C. After centrifugation at 10,000 g for 
20 min at 4°C, pellets were dissolved in 50 µl of 2× Laemmli buffer and 10 µl 
of 1 M Tris-HCl, pH 8.8. 20-µl samples were resolved on a 4–20% SDS–
polyacrylamide gel and transferred to a nitrocellulose membrane. Western 
blot analysis was conducted according to a standard protocol using the 
aforementioned caspase-2 antibody provided by D.C. Huang and L. O’Reilly 
(Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia).
Localization of endogenous caspase-2
SV40-immortalized MEFs were plated onto glass cover slides overnight, 
exposed to the desired stimulus, washed once with PBS, and then fixed 
Southern blotting and PCR analysis
To confirm correct targeting of embryonic stem cells and deletion of the 
pidd gene in tissues, 20 µg total genomic DNA was digested with the ap-
propriate restriction enzymes (DraIII [New England Biolabs, Inc.] for the 3 
probe and MluI and EcoRV [Promega] for the 5 probe) overnight. Samples 
of DNA were size fractioned in 0.7% agarose gels in Tris-acetate-EDTA 
buffer, depurinated in 0.25 M HCl, denatured in 0.4 M NaOH, and trans-
ferred in the same buffer onto Hybond N
+ nylon membranes. Filters were 
probed with 5 and 3 external probes or a neomycin cassette–specific 
probe in Church buffer at 65°C overnight. Membranes were washed in 
40 mM Na-phosphate buffer containing 1% SDS at 65°C and exposed in 
a phosphoimager (Typhoon; GE Healthcare) for up to 2 d.
Littermates from heterozygous (pidd
+/) intercrosses were genotyped 
by PCR using primer pairs specific for the wild-type or the targeted pidd  
allele and the following cycle conditions: 4 min at 94°C; 40 s at 94°C, 30 s   
at 55°C, and 60 s at 72°C for 30 cycles; and 5 min at 72°C. Wild-type 
allele primers used were forward, 5-ACTTCTCCTGGTACTGGCTCTG-3; 
and reverse, 5-AAGGCTGCAAAGAACTTCTCAC-3. Primers used for the 
targeted allele (LacZ) were forward, 5-TGCCACTCGCTTTAATGATG-3;   
and reverse, 5-CTCCACAGTTTCGGGTTTTC-3. The wild-type and targeted 
pidd alleles were amplified in separate reactions yielding PCR products of 
259 bp and 420 bp in size, respectively.
Primers for RT-PCR were designed exon specific for exon 7–8 with 
forward, 5-TCGCTGTCGTGAGGTAGTTG-3, and reverse, 5-GAGAAGT-
GCTCCCTCTGGTG-3; and for exon 13–15 with forward, 5-GGAAGCT-
CAGGATGTTCG-3, and reverse 5-GGTTCAGAGGCATCAAGGAG-3. 
RT-PCR was performed using the following cycle conditions: 5 min at 94°C; 
30 s at 94°C, 30 s at 55°C, and 30 s at 72°C for 30 cycles; and 7 min 
at 72°C.
Cell culture and reagents
MEFs were isolated from embryonic day 13.5 embryos after trypsin diges-
tion and cultured in DME containing 250 µM L-Gln (Invitrogen), penicillin/
streptomycin (Sigma-Aldrich), and 10% FCS. All MEFs used were derived 
from mouse mutants maintained on C57BL/6 genetic background with the 
exception of raidd
/ MEFs, which were derived from mice maintained on 
mixed genetic background (72% B6). Primary MEFs used for experi-
ments were always of low passage (less than five). Alternatively, MEFs 
were immortalized by standard procedures using retroviruses encoding the 
SV40 large T antigen.
Primary  hemopoietic  cells  were  cultured  in  RPMI-1640  medium 
(PAA), 250 µM L-Gln, 50 µM 2-mercaptoethanol, nonessential amino acids 
(Invitrogen), penicillin/streptomycin, and 10% FCS (PAA). For the induction 
of cell death, the following reagents were used: Super Fas ligand (Enzo Bio-
chem, Inc.) at 10 ng/ml, staurosporine (Sigma-Aldrich) at 100 and 500 nM, 
ionomycin (Sigma-Aldrich) at 1 µg/ml, PMA (Sigma-Aldrich) at 10 ng/ml, 
VP16 (Sigma-Aldrich) at 1, 10, or 50 µg/ml, doxorubicin (Sigma-Aldrich) 
at 400 ng/ml, cisplatin (Sigma-Aldrich) at 25, 50, and 100 µM, the ER 
stressors tunicamycin (Sigma-Aldrich) at 0.1–5 µg/ml, brefeldin A at 1.25 
and 2.5 µg/ml, and thapsigargin (Sigma-Aldrich) at 0.05–50 µg/ml, taxol 
(Sigma-Aldrich) at 100–500 µM, cytochalasin D (Sigma-Aldrich) at 2 µM, 
vincristine (EMD) at 50 µg/ml, glucocorticoid dexamethasone (Sigma- 
Aldrich) at 10
7 M, trichostatin A (Sigma-Aldrich) at 50 nM, bortezomib (Vel-
cade; Millennium Pharmaceuticals, Inc.) at 50 ng/ml, and TNF (PeproTech) 
at 10 ng/ml in the absence and presence of cycloheximide (Sigma-Aldrich) 
at 5 µg/ml.  irradiation was performed at 1.25, 2.5, and 5 Gy, and UV-C 
radiation was performed at 5, 10, and 25 mJ/cm
2.
Generation of an mPIDD-reactive antiserum
A 6× His-tagged murine PIDD-DD fragment (aa 770–910) was produced 
in Escherichia coli (strain BL21) from an IPTG-inducible pET21 expression 
vector and purified by column chromatography using Ni–nitrilotriacetic 
acid agarose beads. New Zealand white rabbits were immunized three 
times with 0.5 mg recombinant protein in Freund’s adjuvants. After con-
firming serum reactivity with overexpressed mPIDD, the serum was affinity 
purified using a Sepharose column (GE Healthcare) coupled with PIDD-DD. 
Sera were mixed with PBS in a ratio of 10:1 and loaded onto the column, 
washed with 5 bed volumes of buffer A (20 mM Tris, 5 mM EDTA, 500 mM 
NaCl, and 0.1% NP-40, pH 8.0) followed by 5 bed volumes of buffer B 
(20 mM Tris, 5 mM EDTA, and 150 mM NaCl, pH 8.0). Next, 0.1 M Gly, 
pH 2.8, was added to the column to elute the IgG fraction, which was col-
lected and neutralized by adding 0.1 vol of 1 M Tris buffer, pH 8.8.
Apoptosis assay
Primary thymocytes were cultured at a density of 7.5 × 10
5/ml in 96-well 
plates and treated with a broad range of apoptotic stimuli. After treatment, JCB • VOLUME 185 • NUMBER 2 • 2009   302
Caspase activity assay
Cells were lysed in extraction buffer (10 mM Hepes, 1.5 mM MgCl2, 300 
mM sucrose, 10 mM KCl, 10 mM DTT, 0.5% NP-40, and Complete Prote-
ase Inhibitor Cocktail, pH adjusted to 7.0) for 30 min on ice and spun 
down for 10 min at 10.000 g, and the supernatant was stored at 20°C 
until use. 30 µl of the supernatant (containing 15 µg protein) was trans-
ferred into the well of a 96-well plate, and 100 µl of capsase-3 assay buf-
fer (50 mM Hepes-KOH, pH 7.4, 2 mM EDTA, 10% sucrose (wt/vol), 0.1% 
CHAPS (wt/vol), pH adjusted to 7.4, and 5 mM DTT added freshly from a 
1-M stock), including 100 µM freshly added caspase-3 substrate (Ac-DEVD-
AMC; Enzo Biochem, Inc.), was added. Substrate cleavage activity was 
then measured in a fluorescence microplate reader (Ascent Fluoroscan;   
Titertek) by following fluorescence changes over time with excitation and 
emission wavelengths set at 355 nm and 460 nm, respectively. Enzyme 
activities were normalized to sample protein contents determined by a 
Bradford assay.
Online supplemental material
Fig. S1 shows the specific reactivity of the anti-PIDD polyclonal antiserum. 
Fig. S2 shows that loss of PIDD does not impair lymphocyte development 
or survival in vivo. Fig. S3 shows the colony formation of primary MEFs in 
the absence of PIDD. Fig. S4 shows the colony formation of SV40-MEFs in 
the absence of PIDD. Fig. S5 shows the quantification of caspase activity 
in  the  absence  of  PIDD.  Online  supplemental  material  is  available  at 
http://www.jcb.org/cgi/content/full/jcb.200811105/DC1.
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generated 24 h after transfection (see Biochemical fractionation and immuno-
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ground (B6/SV129; 1:1), were exposed to graded doses of  irradiation 
(2.5–5 Gy) at the age of 8–10 wk. Tissues were collected 20 h after irradi-
ation to prepare single-cell suspensions. Cells were counted in a chamber 
hemocytometer (Neubauer), and aliquots were stained using fluorochrome-
conjugated cell surface marker–specific antibodies followed by flow cyto-
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viving cells were stained 2 wk later using crystal violet.303 PIDDOSOME-INDEPENDENT CASPASE-2 ACTIVATION • Manzl et al.
Krumschnabel, G., B. Sohm, F. Bock, C. Manzl, and A. Villunger. 2009. The 
enigma of caspase-2: the laymen’s view. Cell Death Differ. 16:195–207. 
Lakhani, S.A., A. Masud, K. Kuida, G.A. Porter Jr., C.J. Booth, W.Z. Mehal, I. 
Inayat, and R.A. Flavell. 2006. Caspases 3 and 7: key mediators of mito-
chondrial events of apoptosis. Science. 311:847–851. 
Lin, Y., W. Ma, and S. Benchimol. 2000. Pidd, a new death-domain-containing pro-
tein, is induced by p53 and promotes apoptosis. Nat. Genet. 26:122–127.
Marsden, V.S., P.G. Ekert, M. Van Delft, D.L. Vaux, J.M. Adams, and A. Strasser. 
2004. Bcl-2-regulated apoptosis and cytochrome c release can occur in-
dependently of both caspase-2 and caspase-9. J. Cell Biol. 165:775–780. 
McStay, G.P., G.S. Salvesen, and D.R. Green. 2008. Overlapping cleavage motif 
selectivity of caspases: implications for analysis of apoptotic pathways. 
Cell Death Differ. 15:322–331. 
Michalak, E.M., A. Villunger, J.M. Adams, and A. Strasser. 2008. In several 
cell types tumour suppressor p53 induces apoptosis largely via Puma but 
Noxa can contribute. Cell Death Differ. 15:1019–1029.
O’Reilly,  L.A.,  P.  Ekert,  N.  Harvey, V.  Marsden,  L.  Cullen,  D.L. Vaux,  G. 
Hacker, C. Magnusson, M. Pakusch, F. Cecconi, et al. 2002. Caspase-2 
is not required for thymocyte or neuronal apoptosis even though cleav-
age of caspase-2 is dependent on both Apaf-1 and caspase-9. Cell Death 
Differ. 9:832–841. 
Ogilvy, S., D. Metcalf, C.G. Print, M.L. Bath, A.W. Harris, and J.M. Adams. 
1999. Constitutive bcl-2 expression throughout the hematopoietic com-
partment affects multiple lineages and enhances progenitor cell survival. 
Proc. Natl. Acad. Sci. USA. 96:14943–14948. 
Read, S.H., B.C. Baliga, P.G. Ekert, D.L. Vaux, and S. Kumar. 2002. A novel 
Apaf-1-independent putative caspase-2 activation complex. J. Cell Biol. 
159:739–745. 
Reed, J.C., K.S. Doctor, and A. Godzik. 2004. The domains of apoptosis: a ge-
nomics perspective. Sci. STKE. doi:10.1126/stke.2392004re9. 
Riedl, S.J., and G.S. Salvesen. 2007. The apoptosome: signalling platform of cell 
death. Nat. Rev. Mol. Cell Biol. 8:405–413. 
Robertson, J.D., M. Enoksson, M. Suomela, B. Zhivotovsky, and S. Orrenius. 2002. 
Caspase-2 acts upstream of mitochondria to promote cytochrome c release 
during etoposide-induced apoptosis. J. Biol. Chem. 277:29803–29809. 
Robertson, J.D., V. Gogvadze, A. Kropotov, H. Vakifahmetoglu, B. Zhivotovsky, 
and S. Orrenius. 2004. Processed caspase-2 can induce mitochondria-
mediated apoptosis independently of its enzymatic activity. EMBO Rep. 
5:643–648. 
Schwenk, F., U. Baron, and K. Rajewsky. 1995. A cre-transgenic mouse strain 
for the ubiquitous deletion of loxP-flanked gene segments including dele-
tion in germ cells. Nucleic Acids Res. 23:5080–5081. 
Shi, M., C.J. Vivian, K.J. Lee, C. Ge, K. Morotomi-Yano, C. Manzl, F. Bock, S. 
Sato, C. Tomomori-Sato, R. Zhu, et al. 2009. DNA-PKcs-PIDDosome: 
a nuclear caspase-2-activating complex with role in G2/M checkpoint 
maintenance. Cell. 136:508–520. 
Tinel, A., and J. Tschopp. 2004. The PIDDosome, a protein complex impli-
cated in activation of caspase-2 in response to genotoxic stress. Science. 
304:843–846. 
Tinel, A., S. Janssens, S. Lippens, S. Cuenin, E. Logette, B. Jaccard, M. Quadroni, 
and J. Tschopp. 2007. Autoproteolysis of PIDD marks the bifurcation be-
tween pro-death caspase-2 and pro-survival NF-kappaB pathway. EMBO 
J. 26:197–208. 
Vakifahmetoglu,  H.,  M.  Olsson,  S.  Orrenius,  and  B.  Zhivotovsky.  2006. 
Functional connection between p53 and caspase-2 is essential for apopto-
sis induced by DNA damage. Oncogene. 25:5683–5692. 
Villunger, A., E.M. Michalak, L. Coultas, F. Mullauer, G. Bock, M.J. Ausserlechner, 
J.M. Adams, and A. Strasser. 2003. p53- and drug-induced apoptotic   
responses mediated by BH3-only proteins puma and noxa. Science. 
302:1036–1038. 